Dalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms: a review
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dalbavancin as sequential therapy for infective endocarditis due to Gram-positive organisms: a review
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
Volume 61, Issue 4, Pages 106749
Publisher
Elsevier BV
Online
2023-02-09
DOI
10.1016/j.ijantimicag.2023.106749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of a Standardized Dalbavancin Approach to Facilitate Earlier Hospital Discharge for Vulnerable Patients Receiving Prolonged Inpatient Antibiotic Therapy
- (2020) Axel A Vazquez Deida et al. Open Forum Infectious Diseases
- Dalbavancin for infective endocarditis: a single centre experience
- (2020) Emanuele Durante-Mangoni et al. JOURNAL OF CHEMOTHERAPY
- Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care
- (2020) Leama Ajaka et al. Antibiotics-Basel
- Dalbavancin as Secondary Therapy for Serious Staphylococcus aureus Infections in a Vulnerable Patient Population
- (2019) Chloe Bryson-Cahn et al. Open Forum Infectious Diseases
- Multicenter clinical experience of real life Dalbavancin use in gram-positive infections
- (2019) S. Wunsch et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infections
- (2019) Taylor Morrisette et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- French national cohort of first use of dalbavancin: a high proportion of off-label use
- (2019) Aurélien Dinh et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Serum bactericidal activity levels monitor to guide intravenous dalbavancin chronic suppressive therapy of inoperable staphylococcal prosthetic valve endocarditis: a case report
- (2019) Martina Spaziante et al. Open Forum Infectious Diseases
- DALBACEN cohort: dalbavancin as consolidation therapy in patients with endocarditis and/or bloodstream infection produced by gram-positive cocci
- (2019) Carmen Hidalgo-Tenorio et al. Annals of Clinical Microbiology and Antimicrobials
- Successful treatment of methicillin-sensitive Staphylococcus aureus tricuspid-valve endocarditis with dalbavancin as an outpatient in a person who injects drugs: A case report
- (2019) Aaron Hakim et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of Vienna
- (2018) Selma Tobudic et al. CLINICAL INFECTIOUS DISEASES
- Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis
- (2018) Kasper Iversen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis
- (2018) Manuel Kussmann et al. Emerging Microbes & Infections
- Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety
- (2018) Urania Rappo et al. Open Forum Infectious Diseases
- Unsuccessful treatment of methicillin-resistant Staphylococcus aureus endocarditis with dalbavancin
- (2017) J. M. Steele et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue
- (2015) Michael W. Dunne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection
- (2015) Michael W. Dunne et al. CLINICAL INFECTIOUS DISEASES
- 2015 ESC Guidelines for the management of infective endocarditis
- (2015) Gilbert Habib et al. EUROPEAN HEART JOURNAL
- Prolonged use of oritavancin for vancomycin-resistantEnterococcus faeciumprosthetic valve endocarditis
- (2015) Jennifer A. Johnson et al. Open Forum Infectious Diseases
- Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection
- (2014) Helen W. Boucher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011)
- (2013) Ronald N. Jones et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century
- (2009) David R. Murdoch ARCHIVES OF INTERNAL MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started